Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer.
Onco Targets Ther
; 16: 215-225, 2023.
Article
in En
| MEDLINE
| ID: mdl-37033671
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
Language:
En
Journal:
Onco Targets Ther
Year:
2023
Document type:
Article
Affiliation country:
India